Overview

Effect of Methylprednisolone on Endothelial Function in Patients Undergoing Total Knee-arthroplasty

Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
This study evaluates the pathophysiological effects of a single dose methylprednisolone administered prior to total knee-arthroplasty surgery (TKA). The investigators examine the effect on the endothelial glycocalyx shedding due to surgical trauma. Half of participants will receive intravenous Solu-Medrol 125 mg, while the other half will receive placebo. The investigators hypothesize that the group receiving methylprednisolone will experience reduction in glycocalyx degradation compared to the placebo-group, early after TKA.
Phase:
Phase 3
Details
Lead Sponsor:
Rigshospitalet, Denmark
Collaborator:
Bispebjerg Hospital
Treatments:
Methylprednisolone
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate